Australia Endoscopic Submucosal Dissection Market Size, Share, and COVID-19 Impact Analysis, By Product (Gastroscopes and Colonoscopes, Knives, Injection Agents, Tissue Retractors, Graspers/ Clips, and Others), By Indication (Stomach Cancer, Colon Cancer, and Esophageal Cancer), and Australia Endoscopic Submucosal Dissection Market Size Insights, Industry Trend, Forecasts to 2035

Australia Endoscopic Submucosal Dissection Market Size Insights Forecasts to 2035

• The Australia Endoscopic Submucosal Dissection Market Size Was Estimated at USD 5.6 Million in 2024
• The Market Size is Expected to Grow at a CAGR of Around 7.26% from 2025 to 2035
• The Australia Endoscopic Submucosal Dissection Market Size is Expected to Reach USD 12.1 Million by 2035

According to a Research Report Published by Spherical Insights & Consulting, The Australia Endoscopic Submucosal Dissection Market Size is anticipated to reach USD 12.1 Million by 2035, Growing at a CAGR of 7.26% from 2025 to 2035. The Endoscopic Submucosal Dissection Market Size in Australia is driven by rising rates of gastrointestinal cancer, an aging population, early cancer screening adoption, a preference for minimally invasive procedures, advancements in endoscopy technology, qualified gastroenterologists, reimbursement, and growing public and private healthcare spending.

Market Overview

The Australia Endoscopic Submucosal Dissection (ESD) Market Size represents a healthcare sector that specializes in advanced minimally invasive endoscopic techniques for treating early-stage gastrointestinal tumors. ESD enables doctors to remove stomach and esophagus and colon lesions through exact bloc resection, which reduces the requirement for open surgical procedures. The system provides solutions for diagnosing and treating early-stage gastrointestinal cancers and precancerous lesions and complicated polyps, which leads to better patient results and shorter recovery periods.

The Australian government supports the endoscopic submucosal dissection (ESD) market through bowel cancer screening programs, Medicare reimbursement, and medical innovation funding. The National Bowel Cancer Screening Program provides coverage to more than 2.5 million people each year which helps to improve early detection of gastrointestinal cancers. The funding for innovation comes from MRFF which offers approximately AUD 20 billion in total funding and CRC-P grants which provide funding of about AUD 3 million to support the development of advanced endoscopic technologies and their clinical implementation.

The Endoscopic Submucosal Dissection Market Size of Australia expands because specialized medical centers like Royal Perth Hospital adopt advanced ESD tools which include the Fujifilm Flush Knife and Clutch Cutter. C.R. Kennedy functions as the main distributor which provides essential medical equipment while Australia sees endoscopy companies such as Fuji Film, Olympus, Medtronic and Boston Scientific operating within its borders. The development of new imaging technologies together with AI-based navigation systems and minimally invasive surgical tools will create opportunities for medical facilities to increase their operational capacity and for educational institutions to broaden their training programs.

Report Coverage

This research report categorizes the market for the Australia Endoscopic Submucosal Dissection Market Size based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Australia Endoscopic Submucosal Dissection Market Size. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Australia Endoscopic Submucosal Dissection Market Size.

Driving Factors

The Endoscopic Submucosal Dissection Market Size in Australia is driven by the rising rates of gastrointestinal cancer together with an increasing elderly population and shifting patient preferences toward less invasive surgical methods. The adoption process receives support from hospitals that now offer advanced endoscopic equipment together with high-definition imaging technology and their specialized training programs. The healthcare system in Australia accelerates treatment adoption through its extensive medical facilities and nationwide screening programs and its growing need for organ-conserving medical solutions which are further enhanced by international manufacturers who introduce advances in safety and accuracy and operational effectiveness.

Restraining Factors

The Endoscopic Submucosal Dissection Market Size in Australia is mostly constrained by the high procedure costs, limited availability of highly trained specialists, long learning curves, and reimbursement challenges. The need for major tertiary centres together with the complex nature of procedures and potential complications which arise from them act as barriers that prevent widespread adoption across the country.

Market Segmentation

The Australia Endoscopic Submucosal Dissection Market Size share is classified into product and indication.

• The knives segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. 

The Australia Endoscopic Submucosal Dissection Market Size is segmented by product into gastroscopes and colonoscopes, knives, injection agents, tissue retractors, graspers/ clips, and others. Among these, the knives segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. Due to its crucial involvement in all ESD procedures, single-use or limited reusability, frequent replacements, many knives per case, and ongoing innovation that improves accuracy and safety, the knife segment dominates.

• The stomach cancer segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. 

The Australia Endoscopic Submucosal Dissection Market Size is segmented by indication into stomach cancer, colon cancer, and esophageal cancer. Among these, the stomach cancer segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Compared to colon or esophageal tumors, stomach cancer predominates because early gastric lesions are more frequently identified, more appropriate for ESD, provide excellent curative outcomes, and produce higher procedure volumes.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Australia Endoscopic Submucosal Dissection Market Size, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Endomed Pty Ltd
• Medical Devices Pty Ltd
• Australian Medical Systems
• Medical Australia
• Endoscopy Supplies
• C.R. Kennedy & Company Pty Ltd
• Applied Medical Australia Pty Ltd
• Device Technologies Australia Pty Ltd
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments:

• In September 2025, Boston Scientific announced a planned ESD-oriented endoscopy platform to increase operation efficiency, while Cook Medical unveiled a new line of endoscopic accessories designed for submucosal procedures.

• In March 2025, Focused research activity was shown in the registration of the Australia and New Zealand Multicenter Upper Gastrointestinal Endoscopic Tissue Resection Study (including ESD results).

• In April 2024, FUJIFILM Healthcare Europe introduced the EndoGel simulator to enhance physician proficiency in ESD/POEM training.

Market Segment

This study forecasts revenue at the Australia, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Australia Endoscopic Submucosal Dissection Market Size based on the below-mentioned segments:

Australia Endoscopic Submucosal Dissection Market Size, By Product

• Gastroscopes and Colonoscopes
• Knives
• Injection Agents
• Tissue Retractors
• Graspers/ Clips
• Others

Australia Endoscopic Submucosal Dissection Market Size, By Indication

• Stomach Cancer
• Colon Cancer
• Esophageal Cancer